The abstract is read at the publisher; the summary is JClub's.
CD47hi fibroblasts in fibrotic regions of Crohn’s disease are linked to SIRPAhi macrophages, forming a phagocytic-evasion niche that drives intestinal fibrosis.
- Why it matters: Targeted treatments for intestinal fibrosis in Crohn’s disease are lacking, and it remains unclear how phagocytosis is altered to permit excess matrix deposition.
- What they did: Using single-cell and spatial transcriptomics, the study mapped CD47–SIRPA coupling in fibrotic tissue, then used cell-cell communication and neutralizing antibodies to implicate interleukin-1β. Genetic disruption of fibroblast Cd47 or macrophage Sirpa, plus checkpoint blockade with therapeutic antibodies, tested effects on clearance and fibrosis in mouse models.
- The result: Disrupting CD47–SIRPα enhanced fibroblast clearance, attenuated fibrosis, and reprogrammed macrophages toward an NRF2-associated pro-phagocytic state; antibody blockade reduced fibrosis with schedule-dependent efficacy.
The findingWhy it mattersWhat they didThe result
AI summary of the abstract · may contain errors · not medical advice · read the paper.